BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14654977)

  • 1. Promoter methylation status of multiple genes in brain metastases of solid tumors.
    Gonzalez-Gomez P; Bello MJ; Alonso ME; Amiñoso C; Lopez-Marin I; De Campos JM; Isla A; Gutierrez M; Rey JA
    Int J Mol Med; 2004 Jan; 13(1):93-8. PubMed ID: 14654977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
    Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors.
    Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Amiñoso C; De Campos JM; Isla A; Gutierrez M; Rey JA
    Oncol Rep; 2003; 10(4):1031-3. PubMed ID: 12792765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
    Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
    Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
    Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
    Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
    Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Kusak ME; Gutierrez M; Sarasa JL; Rey JA
    Oncol Rep; 2003; 10(5):1519-23. PubMed ID: 12883734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in pilocytic astrocytomas and medulloblastomas.
    Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; De Campos JM; Vaquero J; Sarasa JL; Casartelli C; Rey JA
    Int J Mol Med; 2003 May; 11(5):655-60. PubMed ID: 12684707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
    Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; Amiñoso C; de Campos JM; Sarasa JL; Gutierrez M; Rey JA
    Cancer Genet Cytogenet; 2003 Apr; 142(1):21-4. PubMed ID: 12660028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas.
    Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Campos JM; Vaquero J; Isla A; Lassaletta L; Gutierrez M; Sarasa JL; Rey JA
    Clin Cancer Res; 2003 Nov; 9(15):5601-6. PubMed ID: 14654541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
    Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
    Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 promoter methylation in human gliomas.
    Amatya VJ; Naumann U; Weller M; Ohgaki H
    Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.